Science
Exploring Cannabidiol as an Adjunctive Treatment in Early Psychosis: A Groundbreaking Study
Researchers are initiating a landmark clinical trial to discover the potential benefits of cannabidiol (CBD) as an adjunctive therapy for individuals experiencing early psychosis. This randomized controlled trial, detailed in the study protocol, aims to assess the efficacy and safety Read more…